EUCTR2005-004639-24-IT进行中(未招募)1 期
Pharmacological intervention study with L-arginin in prevention of diabete type II in patients affected by metabolic syndrome.
OSPEDALE S. RAFFAELE0 个研究点目标入组 294 人开始时间: 2005年10月26日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 294
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Investigation of the effect of oral L-arginine on pulmonary hypertension in patients with thalassemia majorIRCT20191218045785N1Shahre-kord University of Medical Sciences50
已完成
3 期
Investigating the effectiveness of L-arginine in reducing duration of hospitalization and pain intensity of children with sickle cell disease compared to placebo.Sickle cell disease.Other sickle-cell disorders with crisisD57.81IRCT20170112031891N2Ahvaz University of Medical Sciences120
招募中
1 期
Arginine effect on height growth of childreIRCT20230603058376N1Ardabil University of Medical Sciences76
尚未招募
3 期
The effect of L-arginine in non-alcoholic fatty liverIRCT20230409057859N1Shahid Beheshti University of Medical Sciences60
已完成
不适用
Arginine in COVID-19 patientsCTRI/2022/01/039549Clinical Research Centre Dept of Physiology74
